Voglino G, Poso F, Privitera S, Parisio F, Ghiringhello B, Gordini G, Chiara G, Massobrio M, Fessia L
Servizio di Anatomia ed Istologia Patologica e Citodiagnostica, Laboratorio di Patologia Molecolare, Ospedale Sant'Anna, Torino.
Pathologica. 2000 Dec;92(6):516-23.
Many studies have already shown the association of persistent infection of human high risk papillomavirus (HPV) with the development of pre-invasive and invasive cervical disease.
We evaluated the use of high risk HPV testing in a study of about 1908 women, aged 29-78, who attending, from 1996 to 1998, the Sant'Anna Hospital in Turin for routine, second level smears and histopathological diagnosis. We considered all cervical lesions: ASCUS, LSIL, HSIL, squamous and adeno invasive cancers. HPV testing was performed by polymerase chain reaction (PCR) using L1 consensus primers which can detect almost all infections (high and low risk types). The most important high risk HPV types (16, 18, 31, 33 and 35) were tested using specific primers.
The prevalence of high risk HPV was: ASCUS 42.2%, LSIL 39%, HSIL 73.5%, squamous invasive cancers 98.3% and adeno 100%. In addition HPV 16 is the most represented type in all lesions: ASCUS 40%, LSIL 62%, HSIL 71.2% squamous invasive cancers 73.3% and adeno 50.6%. In addition we study the mean age of cervical cancer onset compared with the different high risk HPV types. We found that HPV 18 related cancer occurs in younger women (mean age 41 years; range 39-42).
The addition of high risk HPV testing to cytology may improve early identification of women at risk for cervical cancer.
许多研究已经表明,人类高危型乳头瘤病毒(HPV)的持续感染与宫颈原位癌及浸润癌的发生有关。
我们在一项针对约1908名年龄在29至78岁女性的研究中评估了高危型HPV检测的应用情况。这些女性于1996年至1998年前往都灵的圣安娜医院进行常规二级涂片检查和组织病理学诊断。我们考虑了所有宫颈病变:非典型鳞状细胞意义不明确(ASCUS)、低度鳞状上皮内病变(LSIL)、高度鳞状上皮内病变(HSIL)、鳞状浸润癌和腺癌。HPV检测采用聚合酶链反应(PCR),使用L1通用引物,该引物可检测几乎所有感染(高危型和低危型)。使用特异性引物对最重要的高危型HPV类型(16、18、31、33和35)进行检测。
高危型HPV的患病率分别为:ASCUS为42.2%,LSIL为39%,HSIL为73.5%,鳞状浸润癌为98.3%,腺癌为100%。此外,HPV 16是所有病变中最常见的类型:ASCUS中占40%,LSIL中占62%,HSIL中占71.2%,鳞状浸润癌中占73.3%,腺癌中占50.6%。此外,我们研究了与不同高危型HPV类型相关的宫颈癌发病平均年龄。我们发现,与HPV 18相关的癌症发生在较年轻的女性中(平均年龄41岁;范围39 - 42岁)。
在细胞学检查中增加高危型HPV检测可能会改善对宫颈癌高危女性的早期识别。